171 related articles for article (PubMed ID: 34966679)
1. Ischemic-Free Liver Transplantation Reduces the Recurrence of Hepatocellular Carcinoma After Liver Transplantation.
Tang Y; Wang T; Ju W; Li F; Zhang Q; Chen Z; Gong J; Zhao Q; Wang D; Chen M; Guo Z; He X
Front Oncol; 2021; 11():773535. PubMed ID: 34966679
[TBL] [Abstract][Full Text] [Related]
2. Abrogation of graft ischemia-reperfusion injury in ischemia-free liver transplantation.
Guo Z; Xu J; Huang S; Yin M; Zhao Q; Ju W; Wang D; Gao N; Huang C; Yang L; Chen M; Zhang Z; Zhu Z; Wang L; Zhu C; Zhang Y; Tang Y; Chen H; Liu K; Lu Y; Ma Y; Hu A; Chen Y; Zhu X; He X
Clin Transl Med; 2022 Apr; 12(4):e546. PubMed ID: 35474299
[TBL] [Abstract][Full Text] [Related]
3. A randomized-controlled trial of ischemia-free liver transplantation for end-stage liver disease.
Guo Z; Zhao Q; Jia Z; Huang C; Wang D; Ju W; Zhang J; Yang L; Huang S; Chen M; Zhu X; Hu A; Ma Y; Wu L; Chen Y; Han M; Tang Y; Wang G; Wang L; Li L; Xiong W; Zhang Z; Shen Y; Tang Z; Zhu C; Chen X; Hu X; Guo Y; Chen H; Ma Y; Zhang T; Huang S; Zeng P; Lai S; Wang T; Chen Z; Gong J; Yu J; Sun C; Li C; Tan H; Liu Y; Dong Y; Sun C; Liao B; Ren J; Zhou Z; Andrea S; Björn N; Cai C; Gong F; Rong J; Huang W; Guan X; Clavien PA; Stefan TG; Huang J; He X
J Hepatol; 2023 Aug; 79(2):394-402. PubMed ID: 37086919
[TBL] [Abstract][Full Text] [Related]
4. Prospective, single-centre, randomised controlled trial to evaluate the efficacy and safety of ischaemia-free liver transplantation (IFLT) in the treatment of end-stage liver disease.
Huang C; Huang S; Tang Y; Zhao Q; Wang D; Ju W; Yang L; Zhang J; Wu L; Chen M; Zhang Z; Zhu Z; Wang L; Zhu C; Zhang Y; Sun C; Xiong W; Shen Y; Chen X; Ma Y; Hu A; Zhu X; Rong J; Cai C; Guo Z; He X
BMJ Open; 2020 May; 10(5):e035374. PubMed ID: 32376754
[TBL] [Abstract][Full Text] [Related]
5. Application of ischaemia-free liver transplantation improves prognosis of patients with steatotic donor livers - a retrospective study.
Chen M; Chen Z; Lin X; Hong X; Ma Y; Huang C; He X; Ju W
Transpl Int; 2021 Jul; 34(7):1261-1270. PubMed ID: 33484201
[TBL] [Abstract][Full Text] [Related]
6. Development of a Large Animal Model of Ischemia-free Liver Transplantation in Pigs.
Tang Y; Li J; Wang T; Zhang Z; Huang S; Zhu Z; Wang L; Zhao Q; Guo Z; He X
Transplant Direct; 2024 May; 10(5):e1597. PubMed ID: 38617464
[TBL] [Abstract][Full Text] [Related]
7. Ischaemia-free liver transplantation in humans: a first-in-human trial.
Guo Z; Zhao Q; Huang S; Huang C; Wang D; Yang L; Zhang J; Chen M; Wu L; Zhang Z; Zhu Z; Wang L; Zhu C; Zhang Y; Tang Y; Sun C; Xiong W; Shen Y; Chen X; Xu J; Wang T; Ma Y; Hu A; Chen Y; Zhu X; Rong J; Cai C; Gong F; Guan X; Huang W; Ko DS; Li X; Tullius SG; Huang J; Ju W; He X
Lancet Reg Health West Pac; 2021 Nov; 16():100260. PubMed ID: 34590063
[TBL] [Abstract][Full Text] [Related]
8. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
[TBL] [Abstract][Full Text] [Related]
9. Substantial decline of organ preservation fluid contamination following adoption of ischemia-free liver transplantation: a post-hoc analysis.
Lin J; Li Y; Fang T; Wang T; Liao K; Zhao Q; Wang D; Chen M; Zhu X; Chen Y; Chen H; Guo Y; Zhan L; Zhang J; Zhang T; Zeng P; Peng Y; Yang L; Cai C; Guo Z; He X
Int J Surg; 2024 May; 110(5):2855-2864. PubMed ID: 38329144
[TBL] [Abstract][Full Text] [Related]
10. Propensity-matched analysis of patients with intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma and hepatocellular carcinoma undergoing a liver transplant.
Brandão ABM; Rodriguez S; Fleck AM; Marroni CA; Wagner MB; Hörbe A; Fernandes MV; Cerski CT; Coral GP
World J Clin Oncol; 2022 Aug; 13(8):688-701. PubMed ID: 36160465
[TBL] [Abstract][Full Text] [Related]
11. Post-transplant infection improves outcome of hepatocellular carcinoma patients after orthotopic liver transplantation.
Chao JS; Zhao SL; Ou-Yang SW; Qian YB; Liu AQ; Tang HM; Zhong L; Peng ZH; Xu JM; Sun HC
World J Gastroenterol; 2019 Oct; 25(37):5630-5640. PubMed ID: 31602163
[TBL] [Abstract][Full Text] [Related]
12. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
[TBL] [Abstract][Full Text] [Related]
13. A marginal liver graft with hyperbilirubinemia transplanted successfully by ischemia-free liver transplantation.
Huang C; Chen Z; Wang T; He X; Chen M; Ju W
Ann Transl Med; 2021 Mar; 9(5):425. PubMed ID: 33842646
[TBL] [Abstract][Full Text] [Related]
14. Propensity-Matched Analysis of Patients with Mixed Hepatocellular-Cholangiocarcinoma and Hepatocellular Carcinoma Undergoing Liver Transplantation.
Lunsford KE; Court C; Seok Lee Y; Lu DS; Naini BV; Harlander-Locke MP; Busuttil RW; Agopian VG
Liver Transpl; 2018 Oct; 24(10):1384-1397. PubMed ID: 29573187
[TBL] [Abstract][Full Text] [Related]
15. Early-phase circulating miRNAs predict tumor recurrence and survival of hepatocellular carcinoma patients after liver transplantation.
Ng KT; Lo CM; Wong N; Li CX; Qi X; Liu XB; Geng W; Yeung OW; Ma YY; Chan SC; Man K
Oncotarget; 2016 Apr; 7(15):19824-39. PubMed ID: 26918346
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of Simultaneous Liver Kidney Transplantation in Patients With Hepatocellular Carcinoma.
Rich N; Tanriover B; Singal AG; Marrero JA
Transplantation; 2017 Jan; 101(1):e12-e19. PubMed ID: 28009759
[TBL] [Abstract][Full Text] [Related]
17. Impact of Hypothermic Oxygenated Machine Perfusion on Hepatocellular Carcinoma Recurrence after Liver Transplantation.
Rigo F; De Stefano N; Patrono D; De Donato V; Campi L; Turturica D; Doria T; Sciannameo V; Berchialla P; Tandoi F; Romagnoli R
J Pers Med; 2023 Apr; 13(5):. PubMed ID: 37240873
[TBL] [Abstract][Full Text] [Related]
18. Intraoperative autologous transfusion and oncologic outcomes in liver transplantation for hepatocellular carcinoma: a propensity matched analysis.
Sutton TL; Pasko J; Kelly G; Maynard E; Connelly C; Orloff S; Enestvedt CK
HPB (Oxford); 2022 Mar; 24(3):379-385. PubMed ID: 34294524
[TBL] [Abstract][Full Text] [Related]
19. Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients With Hepatocellular Carcinoma Presenting Beyond Milan Criteria.
Kardashian A; Florman SS; Haydel B; Ruiz RM; Klintmalm GB; Lee DD; Taner CB; Aucejo F; Tevar AD; Humar A; Verna EC; Halazun KJ; Chapman WC; Vachharajani N; Hoteit M; Levine MH; Nguyen MH; Melcher ML; Langnas AN; Carney CA; Mobley C; Ghobrial M; Amundsen B; Markmann JF; Sudan DL; Jones CM; Berumen J; Hemming AW; Hong JC; Kim J; Zimmerman MA; Nydam TL; Rana A; Kueht ML; Fishbein TM; Markovic D; Busuttil RW; Agopian VG
Hepatology; 2020 Dec; 72(6):2014-2028. PubMed ID: 32124453
[TBL] [Abstract][Full Text] [Related]
20. Donor Polymorphisms of Toll-like Receptor 4 rs1927914 Associated with the Risk of Hepatocellular Carcinoma Recurrence Following Liver Transplantation.
Shi G; Wang C; Zhang P; Ji L; Xu S; Tan X; Li H
Arch Med Res; 2017 Aug; 48(6):553-560. PubMed ID: 29221801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
